References
- Astrup T., Darling S. Measurement and properties of antithrombin. Acta physiol. Scandinav 1942; 4: 293
- Bohmansson G., Rosenqvist H., Thorsén G., Wilander O. Clinical experiences with dextran as a plasma substitute. Acta chir. Scandinav 1946; 94: 149
- Ferry J. D., Shulman S. The conversion of fibrinogen to fibrin. I. Influence of hydroxyl compounds on clotting time and clot opacity. J. Am. Chem. Soc 1949; 71: 3198
- Ingelman B. Investigations of dextran and its application as a plasma substitute. Upsala Läkareförenings förhandlingar 1949; 54: 107
- Jacobsson K., Personal communication, not yet published
- Lehman J. Prothrombinbestämning i kliniken. En ny modifikation av Quicks metod. Nord. Med 1941; 12: 3192
- Quick A. J. On various properties of thromboplastin (aqueous tissue extracts). Am. J. Physiol 1935; 114: 282
- Seegers W. H. Purified prothrombin and thrombin, Stabilization of aqueous solutions. Arch. Biochem 1944; 3: 363
- Seegers W. H. Factors which influence the activity of purified thrombin. Am. J. Physiol 1942; 137: 348
- Tager M. Studies on the coagulase-reacting factor 1. The reaction of staphylocoagulase with the components of human plasma. Yale J. Biol. and Med 1947–48; 20: 369
- Tager M. Concentration, partial purification, properties and nature of staphylocoagulase. Yale J. Biol. and Med 1947–48; 20: 487
- Ware A. G., Guest M. M., Seegers W. H. Fibrinogen: With special reference to its preparation and certain properties of the product. Arch. Biochem 1947; 13: 241